RaySearch to highlight software upgrades at AAPM
July 26, 2018 -- Radiation therapy software developer RaySearch Laboratories plans to highlight upgrades to its RayCare and RayStation software packages at the upcoming American Association of Physicists in Medicine (AAPM) meeting in Nashville.
July 26, 2018 -- Radiation therapy software developer RaySearch Laboratories plans to highlight upgrades to its RayCare and RayStation software packages at the upcoming American Association of Physicists in Medicine (AAPM) meeting in Nashville.
FDA clears Mirada's radiation oncology AI software
July 19, 2018 -- The U.S. Food and Drug Administration (FDA) has cleared artificial intelligence (AI) software for radiation oncology treatment planning from imaging software developer Mirada Medical.
July 19, 2018 -- The U.S. Food and Drug Administration (FDA) has cleared artificial intelligence (AI) software for radiation oncology treatment planning from imaging software developer Mirada Medical.
RaySearch updates its RayCare software
July 13, 2018 -- Radiation therapy software developer RaySearch Laboratories has released RayCare 2A, the latest version of its RayCare oncology information system.
July 13, 2018 -- Radiation therapy software developer RaySearch Laboratories has released RayCare 2A, the latest version of its RayCare oncology information system.
IsoRay's GammaTile therapy receives FDA OK
July 11, 2018 -- Medical isotope developer IsoRay has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its GammaTile brachytherapy treatment.
July 11, 2018 -- Medical isotope developer IsoRay has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its GammaTile brachytherapy treatment.
ITG, Bruce Power team up on lutetium-177 production
July 6, 2018 -- German firm Isotope Technologies Garching (ITG) and nuclear reactor operator Bruce Power have signed a memorandum of understanding for the joint production of the radioisotope lutetium-177.
July 6, 2018 -- German firm Isotope Technologies Garching (ITG) and nuclear reactor operator Bruce Power have signed a memorandum of understanding for the joint production of the radioisotope lutetium-177.
Augmenix brings SpaceOAR hydrogel to Japan
July 3, 2018 -- Prostate radiation therapy device developer Augmenix said the Japanese Ministry of Health, Labor, and Welfare has added the firm's Spacing Organs at Risk (SpaceOAR) hydrogel spacer to the national reimbursement program for all men undergoing prostate cancer radiotherapy in Japan.
July 3, 2018 -- Prostate radiation therapy device developer Augmenix said the Japanese Ministry of Health, Labor, and Welfare has added the firm's Spacing Organs at Risk (SpaceOAR) hydrogel spacer to the national reimbursement program for all men undergoing prostate cancer radiotherapy in Japan.
SNMMI: Early prostate cancer therapy extends lives
June 26, 2018 -- PHILADELPHIA - Providing lutetium-177 prostate-specific membrane antigen radioligand therapy earlier to patients with metastatic prostate cancer can extend lives, according to research presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
Discuss
June 26, 2018 -- PHILADELPHIA - Providing lutetium-177 prostate-specific membrane antigen radioligand therapy earlier to patients with metastatic prostate cancer can extend lives, according to research presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
Discuss Radiation oncologists prepare to meet with Congress
June 25, 2018 -- Radiation oncologists from across the U.S. will meet with congressional leaders during the 15th annual American Society for Radiation Oncology Advocacy Day.
June 25, 2018 -- Radiation oncologists from across the U.S. will meet with congressional leaders during the 15th annual American Society for Radiation Oncology Advocacy Day.
Accuray wins Indian market clearance for Radixact X9
June 21, 2018 -- Radiation oncology firm Accuray has received clearance to market its Radixact X9 radiation therapy system in India.
June 21, 2018 -- Radiation oncology firm Accuray has received clearance to market its Radixact X9 radiation therapy system in India.
NorthStar heads toward new radioisotope production
June 18, 2018 -- NorthStar Medical Technologies has provided a progress update on its program to produce the radioisotope actinium-225.
June 18, 2018 -- NorthStar Medical Technologies has provided a progress update on its program to produce the radioisotope actinium-225.
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT